Global Biobanking Congress
Event
biomarker
Cancer blood test firm Grail mulls IPO
Grail, the US-based cancer detection startup backed by billionaires Jeff Bezos and Bill Gates is reportedly mulling a launch on the Hong Kong stock exchange.
Keytruda wins another first with approval based on biomarkers
For the first time, FDA approves drug on the basis of biomarkers, rather than location.
Artificial intelligence: the way ahead for pharma
What has been its impact on the pharma and healthcare sectors?
